The proposed Modification No. M0010 to Contract No. CW94739 with Ramsell Corporation aims to increase the not-to-exceed (NTE) amount of the contract by $3,000,000, raising the total ceiling to $13,500,000. This increase is necessary for Ramsell to continue providing a Pharmacy Benefit Management System (PBMS) for various health programs under DC Health, including the Aids Drug Assistance Program and the Pre-Exposure Prophylaxis program. The additional funding addresses unforeseen costs, particularly due to a projected rise in drug expenditures linked to higher client usage and escalating drug prices. The modification will maintain the contract's firm-fixed price agreement with a cost reimbursement component, effective from January 18, 2025, through January 17, 2026.

Furthermore, the bill outlines a revised price schedule detailing the specific costs associated with the services provided under the contract. The total not-to-exceed amount for both option periods is set at $13,500,000, contributing to a grand total of $52,545,795 for all years of the contract. While the terms and conditions of the contract remain unchanged, the modification ensures continued access to essential prescription coverage and healthcare for District residents infected with HIV who are uninsured or underinsured.